PatternsRadar
Sign in

WOCKPHARMAWockhardt Limited

NSE
2,184.40INR-2.60 (-0.12%)Close · 20 Nov 2026
2 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹35,495 CrMarket cap
86.6P/E (TTM)
32.9%Delivery

Filings & corporate actions

83 results filed
CSV
Next results · Q3 FY27
Expected 27 Jan 2027 – 14 Feb 2027
Estimate: filed 27–45 days after quarter end, last 5 times
Dividend
₹10.00 per share · last 17 Nov 2016
2026
  • 2 NovresultsResults · Q2 FY27 · consolidated and standalone-1.5%NSE
  • 19 OctshareholdingShareholding · 30 Sept 2026-2.5%NSE
  • 10 AugresultsResults · Q1 FY27 · consolidated and standalone-1.1%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026-1.4%NSE
  • 4 MayresultsResults · Q4 FY26 · consolidated and standalone+7.9%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+0.6%NSE
  • 10 FebresultsResults · Q3 FY26 · consolidated and standalone+1.3%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025-0.7%NSE

Reaction to results · all yearsrose on day 0 in 31 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY272 Nov 2026-1.5%+7.1%—1.9×
Q1 FY2710 Aug 2026-1.1%-3.7%+15.2%1.6×
Q4 FY264 May 2026+7.9%+10.2%+45.5%27.4×
Q3 FY2610 Feb 2026+1.3%-1.1%-7.5%4.8×
Q2 FY263 Nov 2025-3.4%-3.8%+0.1%1.4×
Q1 FY268 Aug 2025-0.6%+1.4%+6.0%0.9×
Q4 FY2529 May 2025+8.8%+11.8%+21.8%6.0×
Q3 FY257 Feb 2025-3.1%-16.1%-23.7%1.0×
Q2 FY2513 Nov 2024-1.6%+8.9%+28.7%0.8×
Q1 FY259 Aug 2024+3.0%+2.8%+8.8%2.4×
Q4 FY2428 May 2024+0.6%-7.1%+16.9%2.2×
Q3 FY2414 Feb 2024-1.0%+26.4%+16.0%0.6×
Q2 FY2414 Nov 2023-1.5%+16.5%+42.4%4.6×
Q1 FY2414 Aug 20230.0%-4.6%+3.3%0.4×
Q4 FY2326 May 2023-1.7%-2.3%+34.5%0.6×
Q3 FY2313 Feb 2023-2.6%+0.4%-10.9%1.3×
Q2 FY234 Nov 2022-0.1%-0.9%-4.6%0.7×
Q1 FY2312 Aug 2022-2.3%+8.2%+16.6%1.1×
Q4 FY2231 May 2022+2.4%-0.7%-18.9%0.5×
Q3 FY2227 Jan 20220.0%+0.2%-13.6%0.5×
Q2 FY229 Nov 2021+1.1%-1.3%-6.3%1.2×
Q1 FY2222 Jul 2021-0.4%-3.8%-22.2%0.5×
Q4 FY2128 May 2021-2.4%-2.9%-16.2%0.8×
Q3 FY2129 Jan 2021+0.6%+5.5%+4.0%0.5×
Q2 FY213 Nov 2020-1.6%-2.1%+50.0%1.6×
Q1 FY2129 Aug 2020-5.0%-9.7%-14.7%0.7×
Q4 FY2011 May 2020-4.9%-17.0%+1.1%1.4×
Q3 FY2027 Jan 2020-2.1%-2.7%-3.9%5.9×
Q2 FY208 Nov 2019+0.2%+0.7%-16.7%0.5×
Q1 FY2014 Aug 2019-2.2%-11.7%+11.4%0.8×
Q4 FY1924 May 2019-0.2%-2.1%-5.1%0.6×
Q3 FY1929 Jan 2019+0.9%-7.6%-12.0%1.4×
Q2 FY1919 Nov 2018-2.6%-1.9%-1.2%0.7×
Q1 FY1924 Aug 2018-1.9%+1.5%-13.9%0.8×
Q4 FY1825 May 2018+1.9%-4.2%-2.1%0.6×
Q3 FY1810 Feb 2018+0.8%-5.7%-1.8%0.8×
Q2 FY181 Nov 2017+0.5%+10.2%+10.4%0.9×
Q1 FY184 Aug 20170.0%-5.8%+2.1%0.6×
Q4 FY1716 Jun 2017-6.7%-7.3%-1.2%3.7×
Q3 FY1725 Jan 2017-3.1%-2.5%+3.2%1.3×
Q2 FY1714 Nov 2016-3.0%-12.1%-12.0%0.9×
Q1 FY1728 Sept 2016-4.5%-0.5%-3.7%2.5×
Q4 FY1610 May 2016-1.4%-0.4%-0.1%0.6×
Q3 FY1613 Feb 2016-0.5%+6.4%+28.3%2.5×
Q2 FY1616 Nov 2015+0.3%+5.5%+3.0%0.8×
Q1 FY1611 Aug 20150.0%+1.2%-28.2%1.2×
Q4 FY1529 May 2015+2.0%-9.1%-4.4%0.6×
Q3 FY155 Feb 2015-3.7%+16.4%+31.9%2.4×
Q2 FY157 Nov 2014+4.3%+4.5%+34.0%2.0×
Q1 FY1519 Aug 2014+1.7%+0.7%+21.0%0.7×
Q4 FY1427 May 2014-4.5%-14.9%-19.7%0.8×
Q3 FY1410 Feb 2014+3.5%-1.9%+10.1%2.3×
Q2 FY143 Nov 2013-1.5%+6.0%-11.2%0.4×
Q1 FY1422 Aug 2013-1.4%+7.7%+36.6%0.7×
Q4 FY1310 Jun 2013-10.0%-7.3%-24.0%0.2×
Q3 FY1320 Feb 2013+1.3%+2.5%+3.4%1.2×
Q2 FY1316 Nov 2012-2.1%+0.7%-9.5%0.6×
Q1 FY137 Aug 2012+2.4%+17.5%+21.2%1.3×
Q4 FY1223 May 2012+12.7%+11.5%+23.2%17.4×
Q3 FY1213 Feb 2012+4.7%+10.5%+28.4%6.0×
Q2 FY1217 Nov 2011+0.2%-2.0%-21.4%1.0×
Q1 FY129 Aug 2011-5.9%-13.8%-12.0%2.0×
Q4 FY1119 May 2011+5.6%+0.9%+9.8%7.9×
Q3 FY112 Feb 2011+5.0%-8.4%-8.6%5.2×
Q2 FY1112 Nov 2010+10.8%+7.3%-4.9%4.7×
Q1 FY1113 Aug 2010+17.6%+52.7%+72.1%12.3×
Q3 FY1025 Jan 2010-4.3%-2.3%-15.6%0.6×
Q2 FY1031 Oct 2009-5.1%+5.8%+3.7%1.2×
Q1 FY1030 Jul 2009-4.7%-1.4%+10.1%1.1×
Q3 FY0924 Apr 2009-5.4%-14.1%+19.3%0.4×
Q4 FY0924 Apr 2009-5.4%-14.1%+19.3%0.4×
Q2 FY0921 Oct 2008+0.8%-11.9%-36.1%1.1×
Q1 FY0928 Jul 2008-2.5%+1.5%+3.9%0.8×
Q4 FY0828 Apr 2008-2.4%-0.2%-4.2%3.1×
Q3 FY0820 Feb 2008-1.4%-4.2%-27.0%0.6×
Q2 FY0823 Oct 2007+0.6%-0.2%-3.3%3.5×
Q1 FY0825 Jul 2007+3.3%-2.4%-4.5%2.0×
Q4 FY0726 Apr 2007-2.3%-4.3%-1.6%0.9×
Q3 FY0722 Feb 2007+0.8%+13.4%+16.0%2.9×
Average-0.2%+0.4%+3.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+23.9%
Profit YoY+1.3%
Interest cost YoY+3.3%
Revenue QoQ+4.3%
Profit QoQ-25.5%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+12.8%+10.6%+7.7%+3.8%+4.6%+0.2%
Profit————-10.9%—

Key data

Open2,160.00
Day range2,145.00 – 2,214.50
52-week range1,086.70 – 2,422.30
From 52w high-9.8%
RSI (14)67.6
ATR (14)82.49
Volume9.25L
Avg volume (20D)7.31L
Rel volume1.27×
Volatility (1Y)48.2%
Turnover₹201.2Cr
Traded value (NSE)₹201.2Cr
VWAP2,174.99
SMA 50 / 2002,040.42 / 1,750.60
Price band20%

Delivery percentage

Latest · 20 Nov 202632.9%
20-day avg37.1%
1-year avg36.8%
Percentile (own history)60th
Range4.5–100.0%
Sessions3,504

Over the last 20 sessions WOCKPHARMA settled 37.1% of its traded quantity, which is ordinary for an NSE equity. That is in line with its own one-year average of 36.8%. The latest session ranks higher than 60% of the 3,504 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders—
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy198 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.12%+7.75%+17.73%+19.33%+36.54%+62.35%

Valuation

Market cap₹35,495 Cr
Market cap (NSE)₹35,495 Cr
Free-float cap₹17,989 Cr
P/E (TTM)86.6
P/E (NSE)87.8
EPS (TTM)25.23
P/B6.9
Net margin (TTM)10.9%
Other income / PBT25.2%
ROE8.4%
Debt / equity0.39
Shares outstanding16.20Cr
Listed23 Feb 2000

Ownership

Promoter49.32%
Promoter Δ QoQ+0.24 pp
Public50.68%
FII—
DII—
Pledged—

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)888.0965.0929.0969.0
YoY chg+23.2%+29.9%+25.9%+23.9%
Net profit (₹ Cr)61.0164.0107.073.0
YoY chg+205.0%——-11.0%
Net margin6.9%17.0%11.5%7.5%
EPS3.6110.226.554.85

Shareholding over time

By quarter

30 Sept 2026 · promoter 49.32% · public 50.68%
30 Sept 2021: promoter 68.04%31 Dec 2021: promoter 67.13%28 Mar 2022: promoter 67.13%31 Mar 2022: promoter 67.13%30 Jun 2022: promoter 65.75%30 Sept 2022: promoter 63.83%31 Dec 2022: promoter 60.36%31 Mar 2023: promoter 59.31%30 Jun 2023: promoter 58.40%30 Sept 2023: promoter 55.14%31 Dec 2023: promoter 54.93%26 Mar 2024: promoter 51.60%31 Mar 2024: promoter 51.60%30 Jun 2024: promoter 51.99%30 Sept 2024: promoter 51.99%11 Nov 2024: promoter 49.09%31 Dec 2024: promoter 49.09%31 Mar 2025: promoter 49.09%30 Jun 2025: promoter 49.09%30 Sept 2025: promoter 49.08%31 Dec 2025: promoter 49.08%31 Mar 2026: promoter 49.08%30 Jun 2026: promoter 49.08%30 Sept 2026: promoter 49.32%
2021-092026-09
  • Promoter
  • Public and others
Promoter
49.32%
Public
50.68%
Promoter change
+0.24 pp
Filed
19 Oct 2026
FII
—
DII
—
Promoter pledged
—

Who the public is

Mutual funds
—
Insurance
—
FPI
—
Retail ≤ ₹2L
—
HNI > ₹2L
—
NRI
—
Bodies corporate
—
Shareholders
—

Major holders

As of 30 Jun 2026
HolderTypeHolding
Themisto Trustee Company Private LimitedPromoter · Other40.15%
Pasithee Trustee Company Private LimitedPromoter · Other2.72%
Ananke Trustee Company Private LimitedPromoter · Other2.35%
Tata Mutual Fund - Tata Small Cap FundMutual fund2.03%
Callirhoe Trustee Company Private LimitedPromoter · Other1.92%
Rekha JhunjhunwalaIndividual1.75%
Hsbc Mutual Fund - Hsbc Small Cap FundMutual fund1.30%
3p India Equity Fund 1AIF1.15%
Callirhoe Trustee Company Private LimitedPromoter · Other0.58%
Pasithee Trustee Company Private LimitedPromoter · Other0.40%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 22 Aug 2013 CSV
Financial yearPaymentsDeclaredAdjusted
FY2016-171₹10.00₹10.00
FY2014-151₹20.00₹20.00
FY2013-143₹15.00₹15.00
Ex-dateRecord dateDeclaredAdjusted
17 Nov 2016—₹10.00₹10.00
13 Nov 2014—₹20.00₹20.00
17 Feb 2014—₹5.00₹5.00
7 Nov 2013—₹5.00₹5.00
22 Aug 2013—₹5.00₹5.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
9.6 years ago
Disclosures on record
203
26 open-market of the newest 100
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
1 Sept 2021Ananke Trustee Company Private LimitedPromoterSell3.00L₹12.0Cr399.119.73L → 6.73L0.61%-0.27 pp7(2)told 30 Aug 2021
1 Sept 2021Pasithee Trustee Company Private LimitedPromoterSell5.00L₹20.3Cr405.9010.00L → 5.00L0.45%-0.45 pp7(2)told 30 Aug 2021
1 Sept 2021Themisto Trustee Company Private LimitedPromoterSell5.00L₹22.1Cr441.4238.00L → 33.00L2.98%-0.45 pp7(2)told 30 Aug 2021
1 Sept 2021Themisto Trustee Company Private LimitedPromoterSell5.00L₹21.6Cr432.646.00Cr → 5.95Cr53.69%-0.45 pp7(2)told 30 Aug 2021
31 Aug 2021Akhilesh GuptaDirectorBuy10.0K₹43.9L439.33— → 10.0K0.01%7(2)told 27 Aug 2021
2 Jul 2021Callirhoe Trustee Company Private LimitedPromoterSell1.00L₹5.2Cr519.008.21L → 7.21L0.65%-0.09 pp7(2)told 1 Jul 2021
2 Jul 2021Themisto Trustee Company Private LimitedPromoterSell5.00L₹26.3Cr526.6043.00L → 38.00L3.43%-0.45 pp7(2)told 1 Jul 2021
28 Jun 2021Callirhoe Trustee Company Private LimitedPromoterSell5.00L₹27.7Cr553.0013.21L → 8.21L0.74%-0.45 pp7(2)told 28 Jun 2021
28 Jun 2021Themisto Trustee Company Private LimitedPromoterSell1.00L₹5.4Cr539.0044.00L → 43.00L3.88%-0.09 pp7(2)told 28 Jun 2021
28 Jun 2021Ananke Trustee Company Private LimitedPromoterSell5.00L₹27.9Cr558.6014.73L → 9.73L0.88%-0.45 pp7(2)told 25 Jun 2021
28 Jun 2021Pasithee Trustee Company Private LimitedPromoterSell5.00L₹28.7Cr573.0015.00L → 10.00L0.90%-0.45 pp7(2)told 25 Jun 2021
28 Jun 2021Themisto Trustee Company Private LimitedPromoterSell5.00L₹29.5Cr590.006.05Cr → 6.00Cr54.16%-0.45 pp7(2)told 25 Jun 2021
15 Jun 2021Mahesh PatelEmployeeSell10.0K₹66.1L660.9061.8K → 51.8K0.05%-0.01 pp7(2)told 14 Jun 2021
15 Jun 2021Mahesh PatelEmployeeSell20.0K₹1.3Cr657.1881.8K → 61.8K0.06%-0.02 pp7(2)told 14 Jun 2021
16 Mar 2021Debolina PartapEmployeeSell7.0K₹34.2L489.2615.6K → 8.6K0.01%-0.01 pp7(2)told 15 Mar 2021
19 Feb 2021Ajay SahniEmployeeSell2.5K₹13.0L520.993.3K → 8000.00%0.00 pp7(2)told 17 Feb 2021
14 Dec 2020Mahesh PatelEmployeeSell3.0K₹16.1L536.3778.8K → 75.8K0.07%-0.00 pp7(2)told 14 Dec 2020
2 Jan 2020Themisto Trustee Company Private LimitedPromoterSell5.98L₹14.4Cr241.0449.98L → 44.00L3.97%-0.54 pp7(2)told 31 Dec 2019
27 Nov 2019Pasithee Trustee Company Private LimitedPromoterSell3.00L₹8.5Cr282.7018.00L → 15.00L1.35%-0.27 pp7(2)told 22 Nov 2019
27 Nov 2019Callirhoe Trustee Company Private LimitedPromoterSell4.79L₹12.6Cr263.6918.00L → 13.21L1.19%-0.43 pp7(2)told 22 Nov 2019
27 Nov 2019Themisto Trustee Company Private LimitedPromoterSell4.02L₹11.3Cr280.5454.00L → 49.98L4.51%-0.36 pp7(2)told 22 Nov 2019
27 Nov 2019Ananke Trustee Company Private LimitedPromoterSell3.27L₹9.0Cr274.7718.00L → 14.73L1.33%-0.30 pp7(2)told 22 Nov 2019
16 May 2019Mahesh PatelEmployeeSell2.0K₹7.4L368.5374.8K → 72.8K0.07%-0.00 pp7(2)told 15 May 2019
16 May 2019Ravindra D YeoleEmployeeSell1.3K₹4.8L371.234.5K → 3.2K0.00%0.00 pp7(2)told 14 May 2019
29 Mar 2019Ajay SahniOtherSell1.5K₹6.5L434.172.4K → 9000.00%0.00 pp7(2)told 27 Mar 2019
6 Feb 2019Jerry SaidanhaEmployeeSell3.0K₹12.6L418.9928.1K → 25.1K0.02%-0.00 pp7(2)told 6 Feb 2019

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 6 May 2026

CSV
12 of 62 deals
By year
DateDealClientQuantityPriceValue
6 May 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED10.10L1,720.71₹173.7Cr
6 May 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED10.10L1,720.00₹173.7Cr
1 Jan 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP8.45L456.76₹38.6Cr
1 Jan 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP8.45L456.72₹38.6Cr
12 Dec 2023Sell · bulkGRAVITON RESEARCH CAPITAL LLP9.80L397.26₹38.9Cr
12 Dec 2023Buy · bulkGRAVITON RESEARCH CAPITAL LLP9.80L397.13₹38.9Cr
11 Dec 2023Buy · bulkGRAVITON RESEARCH CAPITAL LLP9.16L373.22₹34.2Cr
11 Dec 2023Sell · bulkGRAVITON RESEARCH CAPITAL LLP9.16L372.83₹34.2Cr
17 Nov 2023Sell · bulkGRAVITON RESEARCH CAPITAL LLP11.48L325.17₹37.3Cr
17 Nov 2023Buy · bulkGRAVITON RESEARCH CAPITAL LLP11.48L324.81₹37.3Cr
16 Nov 2023Buy · bulkGRAVITON RESEARCH CAPITAL LLP18.08L307.02₹55.5Cr
16 Nov 2023Sell · bulkGRAVITON RESEARCH CAPITAL LLP18.08L307.00₹55.5Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 5 May 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban · 20.4% of the market-wide position limit used.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes · ban days · MWPL.

Every stock on this session →

Futures & options · 27 Jun 2019

CSV

Long unwinding — price down as positions closed — longs exiting.

Futures OI
2.59L

₹9.7Cr

OI change
-68.14%
Basis
-2.06%
Rollover
0.0%
PCR (OI)
0.82
PCR (volume)
1.24
Front settle
376.05
Lot size
—

shares

Futures volume
2.0K

contracts

Futures trades
—
Futures value
₹68.7Cr
Sessions shown
250

Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations701.0700.0739.0809.0721.0743.0738.0782.0888.0965.0929.0969.0
Other income8.054.030.09.08.015.020.021.025.045.031.011.0
Total income709.0754.0769.0818.0729.0758.0758.0803.0913.01,010.0960.0980.0
Total expenses796.0934.0775.0827.0708.0780.0770.0712.0836.0843.0844.0907.0
└ Finance costs77.073.073.073.060.048.048.055.060.050.052.056.0
└ Depreciation55.058.054.055.055.053.056.053.065.053.055.055.0
Profit before tax(87.0)(180.0)(6.0)(9.0)21.0(22.0)(109.0)91.067.0189.0116.073.0
Tax expense(1.0)(3.0)10.07.01.023.0(1.0)9.06.025.09.00.0
Net profit(86.0)(177.0)(16.0)(16.0)20.0(45.0)(108.0)82.061.0164.0107.073.0
EPS-5.75-11.64-0.95-1.470.91-1.57-5.534.813.6110.236.554.85
Net margin-12.27%-25.29%-2.17%-1.98%2.77%-6.06%-14.63%10.49%6.87%16.99%11.52%7.53%
PBT margin-12.41%-25.71%-0.81%-1.11%2.91%-2.96%-14.77%11.64%7.55%19.59%12.49%7.53%
Tax rate————4.76%——9.89%8.96%13.23%7.76%0.00%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 2 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets7,683.07,420.07,649.07,588.08,135.08,533.08,615.08,902.0
Current assets1,914.01,739.02,073.01,904.02,465.02,701.02,606.02,764.0
└ Cash & equivalents90.054.0505.0143.0112.0177.0217.0330.0
└ Other bank balances34.030.024.032.079.057.033.0233.0
└ Current investments0.00.00.048.0422.0696.0412.0117.0
└ Trade receivables797.0714.0618.0695.0661.0536.0588.0632.0
└ Inventories658.0635.0640.0657.0725.0866.0887.0973.0
Total equity3,662.03,432.03,662.03,713.04,657.04,876.05,281.05,500.0
└ Attributable to owners3,354.03,125.03,359.03,395.04,353.04,567.04,940.05,158.0
└ Non-controlling interest308.0307.0303.0318.0304.0309.0341.0342.0
└ Share capital72.072.077.077.081.081.081.081.0
Borrowings1,887.02,003.02,112.02,154.01,859.02,323.02,125.02,150.0
└ Current1,663.01,035.01,221.0935.0648.0654.0607.0719.0
└ Non-current224.0968.0891.01,219.01,211.01,669.01,518.01,431.0
Trade payables867.0800.0766.0677.0592.0587.0563.0623.0
Current liabilities3,435.02,685.02,791.02,380.02,042.01,736.01,622.01,785.0
Total liabilities4,021.03,988.03,987.03,875.03,478.03,657.03,334.03,402.0
Net debt1,763.01,919.01,583.01,931.01,246.01,393.01,463.01,470.0
Debt / equity0.520.580.580.580.400.480.400.39
Current ratio0.560.650.740.801.211.561.611.55

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow153.0104.0219.032.0(22.0)189.0390.0237.0
└ Capex(42.0)(94.0)(59.0)(203.0)(365.0)(197.0)(364.0)(238.0)
Free cash flow111.010.0160.0(171.0)(387.0)(8.0)26.0(1.0)
Investing cash flow(125.0)(88.0)(137.0)(247.0)(783.0)(417.0)(241.0)(2.0)
Financing cash flow(315.0)(50.0)334.0(147.0)409.0297.0(54.0)(123.0)
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(280.0)(34.0)415.0(362.0)(393.0)69.095.0112.0

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

WOCKPHARMA at a glance

  • WOCKPHARMA closed at ₹2,184.4 on 20 Nov 2026, -0.12% on the day, +62.3% over one year, 9.8% below its 52-week high of ₹2,422.3.
  • Delivery was 32.9% of traded quantity on 20 Nov 2026, the 60th percentile of its own 3,504 sessions with a reading (20-session average 37.1%, 1-year average 36.8%).
  • Market capitalisation is ₹35,495 crore at a trailing P/E of 86.6 (trailing EPS ₹25.23).
  • Q2 FY27 results (consolidated, filed 2 Nov 2026): revenue ₹969 crore (+23.9% year on year), net profit ₹73 crore (-11.0%); the price moved -1.5% on the first session after.
  • Promoters held 49.32% at 30 Sept 2026, up 0.24 percentage points on the previous filing.
  • Q3 FY27 results are expected between 27 Jan 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE049B01025
SeriesEQ
Listed23 Feb 2000
NSE market cap · 17 Nov 2026₹32,643 Cr
Free-float market cap (NSE)₹16,551 Cr
Shares outstanding (NSE)16.25Cr
History from23 Feb 2000
Sessions6,645
Turnover rank#212

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.